Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II

J Neuroinflammation. 2018 Jan 30;15(1):27. doi: 10.1186/s12974-018-1078-8.

Abstract

Background: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic seizures.

Methods: FCD type II and peri-FCD paired tissues resected from eight children with refractory epilepsy were collected. Through real-time qPCR, Western blot, and co-immunoprecipitation, we examined the differences between FCD lesions and peri-FCD tissues with respect to mRNA expression, protein expression, and protein interaction in HMGB1-TLR4 pathway biomarker and downstream pro-inflammatory factors in whole brain tissue. Then, we used immunofluorescence to examine the difference between FCD lesions and peri-FCD tissues with respect to protein expression and intracellular distribution of HMGB1-TLR4 pathway biomarker in neurons, astrocytes, and oligodendrocytes. Correlation between level of TLR4 expression and disease duration or frequency of epileptic seizures in patients was also analyzed.

Results: The protein expression levels of TLR4, cytoplasm HMGB1, TLR4/MyD88 complex, ubiquitination of TRAF6, p-IKK, p-IκB-α, p-NF-κB p65, and IL-1β and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls. Total mRNA expression levels of TLR4, IL-1β, and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls, but HMGB1 had no significant change. In neurons and astrocytes inside the lesions, the expression of TLR4 protein was significantly higher than that in peri-FCD tissues, and HMGB1 was mainly expressed in the cytoplasm, while expressed in the nuclei in peri-FCD tissues. But in oligodendrocytes, there was no upregulation of HMGB1-TLR4 pathway in both lesions and peri-FCD tissues. We did not identify the correlation between the level of TLR4 activation and disease duration or frequency of epileptic seizures.

Conclusion: The HMGB1-TLR4 pathway was upregulated in the neurons and astrocytes inside FCD type II lesions, which led to an increase in the release of downstream pro-inflammatory cytokines. Correlation between the level of TLR4 activation and duration or frequency of epileptic seizures was not identified.

Keywords: Astrocytes; FCD type II; HMGB1-TLR4; Inflammation; Neurons; Upregulation.

MeSH terms

  • Adolescent
  • Astrocytes / metabolism
  • Astrocytes / pathology
  • Brain / metabolism*
  • Brain / pathology
  • Child
  • Child, Preschool
  • Epilepsy / metabolism*
  • Epilepsy / pathology
  • Female
  • HMGB1 Protein / biosynthesis*
  • Humans
  • Infant
  • Inflammation Mediators / metabolism*
  • Male
  • Malformations of Cortical Development, Group I / metabolism*
  • Malformations of Cortical Development, Group I / pathology
  • Neurons / metabolism
  • Neurons / pathology
  • Toll-Like Receptor 4 / biosynthesis*
  • Up-Regulation / physiology*

Substances

  • HMGB1 Protein
  • HMGB1 protein, human
  • Inflammation Mediators
  • TLR4 protein, human
  • Toll-Like Receptor 4

Supplementary concepts

  • Focal cortical dysplasia of Taylor